Interleukin-37 as an anti-inflammatory cytokine: does its relation to disease activity suggest its potential role in rheumatoid arthritis therapy?
Open Access
- 15 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Egyptian Rheumatology and Rehabilitation
- Vol. 48 (1), 1-9
- https://doi.org/10.1186/s43166-021-00065-2
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Shuangtengbitong tincture treatment of collagen-induced arthritis via downregulation of the expression of IL-6, IL-8, TNF-α and NF-κBExperimental and Therapeutic Medicine, 2012
- Interleukin 37 expression protects mice from colitisProceedings of the National Academy of Sciences of the United States of America, 2011
- The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid ArthritisArthritis, 2011
- In Vivo Expression of Interleukin-37 Reduces Local and Systemic Inflammation in Concanavalin A-Induced HepatitisThe Scientific World Journal, 2011
- IL-37 is a fundamental inhibitor of innate immunityNature Immunology, 2010
- Innate Immunity and Rheumatoid ArthritisRheumatic Disease Clinics of North America, 2010
- The impact of rheumatoid foot on disability in Colombian patients with rheumatoid arthritisBMC Musculoskeletal Disorders, 2009
- Evolving concepts of rheumatoid arthritisNature, 2003
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986
- Radiological Assessment of Osteo-ArthrosisAnnals Of The Rheumatic Diseases, 1957